CLINICAL_TRIALS
trial_result
· 2016-03-17
Clinical Trial Update: Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer [Phase 2]
Summary
This update summarizes a completed Phase 2 safety and toxicity study of sorafenib in patients with renal cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Methodist Hospital Research Institute | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED